$56.60 0.10 (+0.18%)
11/30/2009 10:57 AM

Amgen, Inc. (AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Featured Broker Partners